Activation of AMPK by Medicinal Plants and Natural Products: Its Role in Type 2 Diabetes Mellitus
- 10 July 2019
- journal article
- review article
- Published by Bentham Science Publishers Ltd. in Mini-Reviews in Medicinal Chemistry
- Vol. 19 (11) , 880-901
Abstract
Type-2 Diabetes (T2D) is a metabolic disease characterized by permanent hyperglycemia, whose development can be prevented or delayed by using therapeutic agents and implementing lifestyle changes. Some therapeutic alternatives include regulation of glycemia through modulation of different mediators and enzymes, such as AMP-activated protein kinase (AMPK), a highly relevant cellular energy sensor for metabolic homeostasis regulation, with particular relevance in the modulation of liver and muscle insulin sensitivity. This makes it a potential therapeutic target for antidiabetic drugs. In fact, some of them are standard drugs used for treatment of T2D, such as biguanides and thiazolidindiones. In this review, we compile the principal natural products that are activators of AMPK and their effect on glucose metabolism, which could make them candidates as future antidiabetic agents. Phenolics such as flavonoids and resveratrol, alkaloids such as berberine, and some saponins are potential natural activators of AMPK with a potential future as antidiabetic drugs.Keywords
Funding Information
- National University of La Plata (UNLP) (M-192)
This publication has 177 references indexed in Scilit:
- AMP Is a True Physiological Regulator of AMP-Activated Protein Kinase by Both Allosteric Activation and Enhancing Net PhosphorylationCell Metabolism, 2013
- The Ancient Drug Salicylate Directly Activates AMP-Activated Protein KinaseScience, 2012
- AMPK Is a Direct Adenylate Charge-Regulated Protein KinaseScience, 2011
- Anti-diabetic and hypoglycaemic effects of Momordica charantia (bitter melon): a mini reviewBritish Journal of Nutrition, 2009
- Genetic disruption of AMPK signaling abolishes both contraction- and insulin-stimulated TBC1D1 phosphorylation and 14-3-3 binding in mouse skeletal muscleAmerican Journal of Physiology-Endocrinology and Metabolism, 2009
- The Glycogen-Binding Domain on the AMPK β Subunit Allows the Kinase to Act as a Glycogen SensorCell Metabolism, 2009
- Mechanism of Action of A-769662, a Valuable Tool for Activation of AMP-activated Protein KinaseJournal of Biological Chemistry, 2007
- Structural basis for AMP binding to mammalian AMP-activated protein kinaseNature, 2007
- AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1αProceedings of the National Academy of Sciences, 2007
- The CREB coactivator TORC2 is a key regulator of fasting glucose metabolismNature, 2005